FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Giovanni Migliaccio: Advancing Personalised Medicine for Rare Diseases
In the realm of rare disease research and education, collaboration and knowledge sharing are paramount. Giovanni Migliaccio, the CVBF’s Scientific Director [...]
Our CEO to Present at Prestigious Global CardioVascular Clinical Trialists Workshop
We are proud to announce that Donato Bonifazi, CVBF’s CEO and Member of the Board of Directors of the Teddy European Network [...]
Innovative Therapies and Personalized Medicine for Rare Diseases: MOOC in Full Swing
As we are in full swing of the facilitation window in September, we're excited to share an update on the ongoing online [...]
CVBF’s Researchers Publications in Paediatric Data Standardization
Recent publications from researchers affiliated with the CVBF consortium underscore our commitment to advancing efforts in paediatric data standardization. The [...]
DEEP-2 Lay Summaries for Children and Teens
Thanks to the collaboration with the TEDDY Network, CVBF has published two new lay summaries explaining the key findings [...]
CVBF’s New Video Offers Insights into Multinational Rare Disease Clinical Trials
We are proud to share with you the newly released informative video detailing the challenges and strategies involved in conducting [...]
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was [...]
13 Organizations Across Europe Join Forces for Novel ATMP on Faecal incontinence.
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as our Clinical Project Manager of [...]
New Article on Gabapentin and Tramadol in Paediatric Patients with Chronic Pain
A new article published on 6 October 2023 in the Journal of the British Pharmacological Society titled"Dose rationale for gabapentin and tramadol in paediatric patients [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working Group", opened and led the [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European Alliance for Transformative Therapies (TRANSFORM) [...]
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September 2023, our CEO, Donato Bonifazi [...]
Developed tools for Rare Diseases researchers – ERICA & EJP RD Joint Conference
Bonka Georgieva, CVBF's Project Manager, presented at the "ERICA & EJP RD Joint Conference" held in Amsterdam. The event served as a platform for advancing [...]